Friday 6 November 2026 Export COR’s income statement to Excel — free account

Cencora, Inc.

Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.

Revenue: +5.52%
EPS: +258.4%
Free cash flow: −7.81%
Total debt: +47.1%

Quarter to September 2026, against a year earlier

339.76 14.24 −4.02%

Follow COR

Alert me

Market cap: $64.8B
P/E: 18.8×
Fwd P/E: 17.5×
Dividend yield: 0.71%
F-score: 7/9
Altman Z: n/a
Beneish M: −2.59
Dividend safety: 70/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Cencora, Inc. (COR) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2025: revenue by segment, and margins
U.S. Healthcare Solutions	290,982	90.55%
International Healthcare Solutions	30,366	9.45%
Gross margin		3.57%
Operating margin		0.82%
Pre-tax margin		0.70%

Revenue by segment $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010
U.S. Healthcare Solutions	290,982 90.55%	265,339 90.26%	234,759 89.54%	212,100 88.90%	202,462 94.61%	—	—	—	—	—	—	—	—	—	—
International Healthcare Solutions	30,366 9.45%	28,628 9.74%	27,419 10.46%	26,492 11.10%	11,530 5.39%	—	—	—	—	—	—	—	—	—	—
Pharmaceutical Distribution	—	—	—	—	—	172,814 96.23%	161,699 96.28%	147,453 96.28%	141,702 96.49%	132,384 97.37%	117,384 98.17%	86,064 97.84%	76,690 98.22%	78,445 99.68%	77,553 99.71%
MWI Animal Health	—	—	—	—	—	—	3,790 2.26%	3,636 2.37%	—	—	—	—	—	—	—
Global Commercialization Services	—	—	—	—	—	—	2,543 1.51%	2,112 1.38%	—	—	—	—	—	—	—
Intersegment Eliminations	—	—	—	—	—	—	—	—	—	—	—	—	(184) (0.24%)	(51) (0.07%)	(38) (0.05%)
Other Segments	—	—	—	—	—	—	6,333	5,748	—	—	—	—	—	—	—
Revenue	321,333	293,959	262,173	238,587	213,989	179,589	167,940	153,144	146,850	135,962	119,569	87,959	78,081	78,696	77,776

Operating income by segment $m, and margin

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010
U.S. Healthcare Solutions	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
International Healthcare Solutions	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Pharmaceutical Distribution	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Other Segments	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Operating Segments	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Corporate and other	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Operating income	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.